Analysts Viewpoint
PHAT price target predicted to rise nearly 18 in 12 months
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals
Menu
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals
Phathom Pharmaceuticals Inc’s recent filing unveils that its Principal Accounting Officer Breedlove Robert Charles unloaded Company’s shares for reported $14152.0
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals
Phathom Pharmaceuticals Inc’s recent filing unveils that its Director Topper James N acquired Company’s shares for reported $14609.0 on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals
Phathom Pharmaceuticals Inc’s filing revealed that its Director Topper James N acquired Company’s shares for reported $14609.0 on May 21
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals
In a filing, Phathom Pharmaceuticals Inc revealed its Director Topper James N acquired Company’s shares for reported $14609.0 on May
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Phathom Pharmaceuticals
Phathom Pharmaceuticals Inc’s recent filing unveils that its Director Topper James N acquired Company’s shares for reported $14609.0 on May